Embolization Particles Market Size by Segments, Share, Regulatory, Reimbursement, Procedures and Forecast to 2033
Powered by
All the vital news, analysis, and commentary curated by our industry experts.
Embolization Particles Market Report Overview
The embolization particles market size was valued at $409.3 million in 2023 and is forecast to grow at a CAGR of more than 3% during 2023 and 2033. Embolization particles are used to stop bleeding or are used to block the flow of blood to a tumor. Embolization Particles are generally used to treat liver cancer, renal cell carcinoma, kidney cancer, neuroendocrine tumors, arteriovenous malformation, uterine fibroids, and benign prostatic hyperplasia.
Embolization Particles Market Outlook, 2023-2033 ($ Million)
Buy The Full Report For More Insights Into The Embolization Particles Market Forecast, Download A Free Report Sample
The embolization particles market research report explains the market behavior, which will help identify quantitative market trends within the general surgery devices therapeutic area. The model discusses in detail the impact of COVID-19 on the embolization particles market for the year 2020 and beyond. The report has extensively covered pipeline products and technologies, which will help in identifying companies with the most robust pipeline. This, in turn, will assist in predictive analysis for designing in-licensing and out-licensing strategies.
Market Size (2023) | $409.3 Million |
CAGR (2023-2033) | >3% |
Forecast period | 2023-2033 |
Historical Period | 2015-2022 |
Key Regions | North America, Europe, Asia Pacific, South Central America, and The Middle East and Africa |
Key Segments | Radioembolization Particles, Drug-Eluting Beads, Microspheres, and Polyvinyl Alcohol (PVA) Particles |
Leading Companies | Boston Scientific Corp, Merit Medical Systems Inc, Sirtex Medical Ltd, Terumo Corp, Cook Medical Inc, and Varian Medical Systems Inc |
Embolization Particles Market Dynamics
The embolization particles market is driven by a wide variety of factors including the growing aging population, a rise in the number of patients with liver cancer, renal cell carcinoma, kidney cancer, neuroendocrine tumors, arteriovenous malformation, uterine fibroids, and benign prostatic hyperplasia.
Embolization Particles Market Segment
The key segments in the embolization particles market are radioembolization particles, drug-eluting beads, microspheres, and polyvinyl alcohol (PVA) particles. Radioembolization particles accounted for the highest share of the embolization particles market in 2023.
Embolization Particles Market Analysis by Segments, 2023 (%)
Buy The Full Report For More Information The Embolization Particles Market Segments, Download A Free Report Sample
Embolization Particles Market Segmentation by Regions
The key regions in the embolization particles market are North America, Europe, Asia Pacific, South Central America, and the Middle East and Africa. North America accounted for the largest share of the overall market in 2023. It is expected to retain its position during the forecast period with the US being the largest contributor to the regional market. With the growing incidence of liver cancer, metastasis, renal cell carcinoma, kidney cancer, neuroendocrine tumors, arteriovenous malformation, uterine fibroids, and benign prostatic hyperplasia, utilization of embolization particles will increase in the region. Moreover, due to technological advances, patient adherence is improving.
Embolization Particles Market Analysis by Region
Buy The Full Report For More Information Regional Insights into the Embolization Particles Market, Download A Free Report Sample
Embolization Particles Market - Competitive Landscape
Some of the leading companies in the embolization particles market are Boston Scientific Corp, Merit Medical Systems Inc, Sirtex Medical Ltd, Terumo Corp, Cook Medical Inc, and Varian Medical Systems Inc. Boston Scientific Corp accounted for the highest share of the market in 2023.
Embolization Particles Market Analysis by Companies, 2023 (%)
Buy The Full Report To Know More About The Leading Companies In The Embolization Particles Market, Download A Free Report Sample
Embolization Particles Segments Outlook (Value, US$ Million, 2015-2033)
- Radioembolization Particles
- Drug-Eluting Beads
- Microspheres
- Polyvinyl Alcohol (PVA) Particles
Embolization Particles Regional Outlook (Value, US$ Million, 2015-2033)
- North America
- Europe
- Asia Pacific
- South Central America
- Middle East and Africa
Scope
- This Market Model gives important, expert insight you won’t find in any other source. The model illustrates qualitative and quantitative trends within the specified market. This model is required reading for –
- CMO executives who must have deep understanding of the Embolization Particles marketplace to make strategic planning and investment decisions.
- Sourcing and procurement executives who must understand crucial components of the supply base in order to make decisions about supplier selection and management.
- Private equity investors that need a deeper understanding of the market to identify and value potential investment targets.
Reasons to Buy
The model will enable you to –
- Understand the impact of COVID-19 on the Embolization Particles market.
- Develop and design your in-licensing and out-licensing strategies through a review of pipeline products and technologies, and by identifying the companies with the most robust pipeline.
- Develop business strategies by understanding the trends shaping and driving the Embolization Particles market.
- Drive revenues by understanding the key trends, innovative products and technologies, market segments, and companies likely to impact the Embolization Particles market in the future.
- Formulate effective sales and marketing strategies by understanding the competitive landscape and by analyzing the company’s share of market leaders.
- Identify emerging players with potentially strong product portfolios and create effective counter-strategies to gain a competitive advantage.
- Track device sales in the global and country-specific Embolization Particles market from 2015-2030.
- Organize your sales and marketing efforts by identifying the market categories and segments that present maximum opportunities for consolidations, investments, and strategic partnerships.
Merit Medical Systems Inc
CDH Investment Management Company Limited
Terumo Corp
Cook Group Inc
Siemens Healthineers AG
Others
Frequently asked questions
-
What was the size of the embolization particles market in 2023?
The embolization particle market size was $409.3 million in 2023.
-
What will be the embolization particles market CAGR during the forecast period?
The embolization particle market will grow at a CAGR of more than 3% during 2023 and 2033.
-
Which was the leading region in the embolization particles market in 2023?
North America has the largest share of the overall market, and the region is expected to retain its position during the forecast period.
-
Which segment accounted for the largest embolization particles market share in 2023?
Radioembolization Particles led the embolization particles market in 2023.
-
Who are the major players operating in the embolization particles market?
Some of the leading companies in the embolization particles market are Boston Scientific Corp, Merit Medical Systems Inc., Sirtex Medical Ltd, Terumo Corp, Cook Medical Inc., and Varian Medical Systems Inc.
Get in touch to find out about multi-purchase discounts
reportstore@globaldata.com
Tel +44 20 7947 2745
Every customer’s requirement is unique. With over 220,000 construction projects tracked, we can create a tailored dataset for you based on the types of projects you are looking for. Please get in touch with your specific requirements and we can send you a quote.